Agrimony — Benefits Deep Dive

Agrimony (Agrimonia eupatoria) is the tall, slender rose-family herb of European hedgerows that country people called church steeples, after its long spike of small yellow flowers. It has one defining property, and everything worth saying about the herb follows from it: astringency. The dried aerial parts are loaded with tannins — including agrimoniin, a distinctive ellagitannin — and tannins bind proteins. That is why a cup of agrimony puckers the mouth like strong stewed tea, and it is the whole of the herb's plausible mechanism.

What makes astringency such a clarifying starting point is that it is a physical action, not a pharmacological one. Tannins precipitate proteins on the wet surface they touch, and large hydrolysable tannins are barely absorbed, so their effects live where they land and nowhere else. That single fact both explains and limits the traditional uses. It explains why mild acute diarrhoea and a sore-throat gargle are agrimony's most defensible indications: those are surfaces the herb reaches directly, at a concentration you produce yourself. And it limits everything requiring the herb to enter the bloodstream — liver tonic, urinary tonic, systemic antioxidant support — because a compound that stays in the gut lumen cannot act on tissue it never reaches. It is the same argument, in mirror image, that governs demulcents like marshmallow root: chemically opposite, epistemically identical.

These four articles follow that spine honestly, including where it leads somewhere unflattering. Europe's traditional-use registration for agrimony is real and worth understanding — and it certifies documented long use plus plausibility plus an acceptable safety record, explicitly not efficacy trials. No adequate controlled human trial of agrimony for diarrhoea or sore throat exists, which we state as a finding rather than leave as a silence. And the herb's best-evidenced action turns out to be an interaction rather than a benefit: tannins reduce non-haem iron absorption, established in humans for the compound class, unmeasured for agrimony specifically. There is also a completely separate product sold under this plant's name — the Bach flower remedy — which gets its own article, because a reader searching "agrimony benefits" may land on either and they are not the same thing.

Deep-Dive Articles

Agrimony for Diarrhoea: Astringency and Tannins

The spine of the whole case. What astringency physically is, why agrimoniin and its fellow tannins act locally and are barely absorbed, what the diarrhoea tradition actually claims, and the six specific studies that have never been done. Includes tormentil root — the closely related tannin astringent that does have a randomised paediatric trial — as proof that the question is answerable and simply has not been asked of agrimony.

Agrimony for Sore Throat and Topical Use

Agrimony's strongest argument, because a gargle removes the absorption problem entirely: you put the herb on the tissue yourself, at whatever strength you like. Covers what a gargle can and cannot reach, gums and mouth ulcers, the in-vitro antimicrobial data and its four limits, the wound-washing tradition as history — and the trial of plain-water gargling that confounds every favourable personal impression.

Agrimony the Herb vs Agrimony the Bach Flower Remedy

Two unrelated products, one plant name, and a confusion that runs both ways. What Bach Agrimony is, how the sun method actually works, the dilution arithmetic with its assumptions shown, why it is homeopathy's cousin rather than a subset — and the randomised placebo-controlled trials, which came out null. Reported plainly and without contempt: the type description is psychologically acute even though the bottle is inert.

Agrimony Safety: Iron, Interactions and Dose

The most practically useful page in the set, because agrimony's interaction rests on better evidence than its benefits. Tannins and non-haem iron, who is most exposed, the two-hour timing fix and the controlled human study it comes from, vitamin C as a partial counter, medicines that must be separated, gastric irritation, the animal glucose data read as a caution, the haemostatic-versus-anticoagulant contradiction, and six numbers we refuse to invent.


Table of Contents

  1. Deep-Dive Articles
  2. The Spine: One Mechanism, Explaining and Limiting
  3. Evidence Ledger
  4. What "Registered in Europe" Actually Means
  5. Two Agrimonies, and Two Species
  6. Contradictions We Are Not Resolving
  7. Folk Medicine, Presented as History
  8. Who Should Leave This Herb Alone
  9. Key Research
  10. External Resources
  11. Connections

The Spine: One Mechanism, Explaining and Limiting

Astringency is a physical event on a wet surface. Tannins are large polyphenols whose many hydroxyl groups make them promiscuous protein binders; when a tannin-rich liquid washes over a mucous membrane, it cross-links proteins in the surface mucus and in the outermost cells, and those complexes precipitate. The puckering you feel is a mucus layer losing its slipperiness.

Three consequences set the ceiling on the herb, and they are worth holding in mind while reading anything else about it:

Evidence Ledger

Ranked deliberately against the popular narrative rather than with it, so the asymmetry is visible rather than argued. Note what sits at the top.

  1. Tannins reduce non-haem iron absorption. Tier: established, human — for the compound class, in controlled studies using tea. Magnitude for agrimony: unmeasured. This is the best-evidenced statement in the whole agrimony literature, and it is a hazard.
  2. A time interval largely defuses that interaction. Tier: established, human — a controlled stable-isotope trial with tea. This is the best-supported recommendation on the site's agrimony pages.
  3. Concentrated tannin irritates the gastric mucosa and can cause constipation. Tier: established, class-level. Well described for astringents generally.
  4. Agrimony is astringent, and the astringency is chemically characterised. Tier: established, analytical — validated HPLC standardisation of its polyphenols exists. Also verifiable on your own tongue.
  5. Agrimony extracts are antioxidant, antimicrobial and antibiofilm in vitro. Tier: laboratory. Relevant to a gargle, where high local concentration is genuinely achievable; largely irrelevant to systemic claims, because absorption is poor.
  6. Agrimony lowers blood glucose in mice. Tier: animal. Weak as a benefit claim, worth acting on as a caution — the asymmetry of consequences decides.
  7. Agrimony infusion eases mild acute diarrhoea. Tier: tradition plus plausible mechanism. No adequate controlled human trial exists.
  8. Agrimony gargle eases sore throat and minor mouth inflammation. Tier: tradition plus plausible mechanism, with the best mechanistic case of any agrimony claim. No trial exists, and plain-water gargling has a positive trial, which confounds informal impressions.
  9. Agrimony wash helps minor wounds. Tier: history, with one formulation-level in-vitro study on Anglo-Saxon recipes that cannot attribute activity to agrimony alone.
  10. Agrimony supports the liver or urinary tract. Tier: tradition only, and the mechanism does not supply the systemic delivery these claims require.
  11. Bach Agrimony improves emotional concealment. Tier: tested and null. A separate product entirely; randomised placebo-controlled trials of Bach flower remedies have not shown effects beyond placebo. This is stronger evidence than the herb has in either direction.

Read items 1 to 3 against items 7 to 10. Agrimony's three best-established properties are all safety properties. That is not a hostile reading; it is what the literature says when it is sorted by evidence tier instead of by enthusiasm.

What "Registered in Europe" Actually Means

Agrimony's European traditional-use registration covers the infusion for mild acute diarrhoea and the preparation as a gargle for minor inflammation of the mouth and throat. It is cited constantly as validation, and it is almost always misread, so the instrument is worth understanding rather than quoting.

A traditional-use registration is granted on three things: documented use over a long period — conventionally at least thirty years, including a stretch within the European Union — a plausible pharmacological rationale, and an acceptable safety record at the traditional dose. Assessors read the historical literature, examine the chemistry, and satisfy themselves the preparation is not dangerous and the claimed action is not absurd. They do not require adequate controlled trials demonstrating efficacy, and that is the stated design of the category rather than an oversight. The labelling says so explicitly: such products are described as traditional herbal medicinal products used for an indication based exclusively on long-standing use. Regulators wrote that clause so their registration could not be mistaken for an efficacy finding.

So the honest reading of agrimony's registration is: this use is genuinely documented rather than invented, the chemistry is consistent with the claim, and the safety record at traditional doses passed inspection. Three worthwhile facts, none of them evidence of benefit. Understanding this also dissolves apparent paradoxes elsewhere — one regulator granting a traditional-use registration while another finds the same plant not generally recognised as effective is not a contradiction. They answered different questions.

Two Agrimonies, and Two Species

Two distinct identity problems get tangled together in popular writing about this plant, and separating them prevents most of the errors.

Two products. "Agrimony" names both a tannin-rich herbal infusion and a Bach flower remedy — an extremely dilute sun-infused flower preparation for a described emotional pattern. They share nothing but the species on the label: not the plant part, not the preparation, not the concentration, not the indication, not the proposed mechanism, not the evidence base. Neither can borrow the other's credibility, and the traffic runs both ways. Citing the herb's registration for the essence attaches a regulatory finding to a product it never examined; citing the essence's null trials against the herb attributes a psychological result to a mucosal mechanism. See the Bach article.

Two species. Agrimonia eupatoria is the European plant in a European teabag. Agrimonia pilosa is the East Asian species used in Chinese medicine as Xian He Cao, classified there among the haemostatic herbs. They are related and share ellagitannin chemistry, but they are not the same plant — and a good deal of the more exciting pharmacology attributed to "agrimony," particularly older work on agrimoniin's immunostimulant and antitumour activity in mice, was done on A. pilosa. A third species, A. procera, appears as a commercial substitute; radical-scavenging work has examined both European species and found activity in each, so the substitution is probably chemically benign — but it is still a substitution. Check the species before crediting a finding to your cup.

Contradictions We Are Not Resolving

Unresolved tensions are more informative than a tidy summary, so they are stated rather than smoothed over.

Folk Medicine, Presented as History

Agrimony's place in European folk medicine is genuinely deep, and it is offered here as history rather than as evidence — which is the only honest way to present it and, as it happens, the most interesting.

The plant appears among the herbs named in Anglo-Saxon medical recipes, and the tradition of bathing cuts, grazes and weepy skin with a cooled infusion continued in European domestic medicine into the twentieth century. It carried a reputation as a wound herb (a vulnerary), as a gentle liver and gallbladder "spring tonic," and as a mild urinary remedy. The species epithet eupatoria nods to Mithridates Eupator, the ancient king associated with medicinal plants. Country names record what people noticed: church steeples for the flower spike, sticklewort and cocklebur for the hooked burr-seeds that catch on trouser legs.

One piece of modern work touches this tradition and deserves accurate framing. Antimicrobial assays of native British plants used in tenth-century Anglo-Saxon wound-healing formulations found real antibacterial activity in the plants involved. That is a legitimate vindication of the historical record's internal logic — the people writing those recipes were selecting plants that do something in a Petri dish. It is not a clinical trial, and it tested plants used together in a formulation, which cannot attribute activity to agrimony alone.

Who Should Leave This Herb Alone

In brief, with the reasoning on the safety page:

Back to Table of Contents


Key Research

Grouped by theme. Every entry names the paper, journal and year in prose and links a PubMed search rather than a record number, so you see the surrounding literature rather than a single identifier. Where a study is not about agrimony, it is labelled borrowed evidence in place.

1. Chemistry, Standardisation and Why We Quote No Percentages

  1. Granica S and colleagues (2013) — development and validation of an HPLC method for qualitative and quantitative standardisation of polyphenols in Agrimoniae eupatoriae herba, Journal of Pharmaceutical and Biomedical Analysis. Analytical chemists build standardisation methods for materials whose content varies; this is why no tannin percentage appears anywhere in this Benefits leg. PubMed search
  2. Correia HS and colleagues (2006) — polyphenolic profile characterisation of Agrimonia eupatoria by HPLC with different detection devices, Biomedical Chromatography. PubMed search
  3. Paluch Z and colleagues (2020) — a review of the therapeutic effects of Agrimonia eupatoria, Physiological Research. The most convenient single overview; read it noting how much of the cited pharmacology is preclinical. PubMed search
  4. Topic searchagrimoniin, the herb's signature ellagitannin. Much of this literature concerns Agrimonia pilosa, not the European species. Hydrolysable tannin bioavailability is the search that explains why the mechanism stays local.

2. Preclinical Pharmacology: Antioxidant, Antimicrobial, Metabolic

  1. Correia H, Batista MT, Dinis TC (2007) — activity of an extract and fraction of Agrimonia eupatoria against reactive species, BioFactors. Real chemistry; a tube is not a bloodstream. PubMed search
  2. Ivanova D and colleagues (2005) — polyphenols and antioxidant capacity of Bulgarian medicinal plants, Journal of Ethnopharmacology; ranks agrimony among the high-polyphenol traditional herbs. PubMed search
  3. Venskutonis PR and colleagues (2007) — radical scavenging capacity of Agrimonia eupatoria and Agrimonia procera, Fitoterapia. Directly relevant to the commercial species substitution. PubMed search
  4. Muruzović MŽ and colleagues (2016)Agrimonia eupatoria extracts evaluated for antioxidant, antimicrobial and antibiofilm activity, Journal of Food and Drug Analysis. The antibiofilm result is the most relevant to an oral rinse, dental plaque being a biofilm. PubMed search
  5. Cwikla C and colleagues (2010) — antibacterial activity of phytotherapeutics against Helicobacter pylori and Campylobacter jejuni, Phytotherapy Research. Gut pathogens are among the few targets a poorly absorbed tannin can actually reach at concentration. PubMed search
  6. Copland A and colleagues (2003) — antibacterial and free-radical-scavenging activity of the seeds of Agrimonia eupatoria, Fitoterapia. Note the plant part — seeds, not the aerial parts used in a tea or gargle. PubMed search
  7. Gray AM, Flatt PR (1998) — actions of agrimony on hyperglycaemia, cellular glucose metabolism and insulin secretion, British Journal of Nutrition; and Swanston-Flatt SK and colleagues (1990), traditional plant treatments for diabetes in normal and streptozotocin-diabetic mice, Diabetologia. Animal data, weak as a benefit claim and worth acting on as a caution. PubMed search

3. Astringents in the Clinic: the Borrowed and the Comparable

  1. Subbotina MD and colleagues (2003) — randomised, double-blind, controlled trial of tormentil root extract in children with rotavirus diarrhoea, Pediatric Infectious Disease Journal. Borrowed evidence: Potentilla erecta, not agrimony. Proof that the tannin-astringent hypothesis is testable, and that it has not been tested for agrimony. PubMed search
  2. Schapowal A and colleagues (2009) — randomised double-blind comparison of an echinacea/sage spray with a chlorhexidine/lidocaine spray for acute sore throat, European Journal of Medical Research; and Hubbert M and colleagues (2006) on a Salvia officinalis spray in acute pharyngitis. Borrowed evidence: sage, not agrimony, and a spray rather than a gargle. PubMed search
  3. Chamomile mouthwash for fluorouracil-induced oral mucositis (1996) — a prospective evaluation in Cancer that did not confirm the benefit suggested by uncontrolled use. Included deliberately: the base rate for plausible traditional botanical rinses surviving a controlled trial is not 100%. PubMed search
  4. Satomura K and colleagues (2005) — prevention of upper respiratory tract infections by gargling, a randomised trial, American Journal of Preventive Medicine, in which water gargling was associated with fewer infections. The confounder that undermines any informal impression of a herbal gargle. PubMed search
  5. Watkins F and colleagues (2012) — antimicrobial assays of native British plants used in Anglo-Saxon wound-healing formulations, Journal of Ethnopharmacology. Formulation-level testing; cannot attribute activity to agrimony alone. PubMed search
  6. Comparators with real trials for acute diarrhoeaLazzerini M, Wanzira H on oral zinc in children, Collinson S and colleagues (2020) on probiotics for acute infectious diarrhoea (notable for downgrading earlier optimism), and the Cochrane reviews of reduced-osmolarity oral rehydration solution, all in the Cochrane Database of Systematic Reviews. Zinc · Probiotics · Oral rehydration

4. Tannins, Iron and Drug Absorption in Humans

  1. Disler PB and colleagues (1975)The effect of tea on iron absorption, Gut. The foundational human demonstration. PubMed search
  2. Brune M, Rossander L, Hallberg L (1989) — iron absorption and phenolic compounds: importance of different phenolic structures, European Journal of Clinical Nutrition. Establishes that the inhibition is structure-dependent, which is what licenses transferring it to agrimony's galloyl-bearing tannins — direction only, never magnitude. PubMed search
  3. Hurrell RF, Reddy M, Cook JD (1999) — inhibition of non-haem iron absorption in man by polyphenolic-containing beverages, British Journal of Nutrition. PubMed search
  4. Ahmad Fuzi SF and colleagues (2017) — a controlled stable-isotope trial in healthy UK women showing that a one-hour interval between an iron-containing meal and tea attenuates the inhibition, American Journal of Clinical Nutrition. The source of the timing advice these pages lead with. PubMed search
  5. Siegenberg D and colleagues (1991) — ascorbic acid prevents the dose-dependent inhibitory effects of polyphenols and phytates on non-haem iron absorption, American Journal of Clinical Nutrition. A partial counter, not a licence to combine. PubMed search
  6. Chung KT and colleagues (1998)Tannins and human health: a review, Critical Reviews in Food Science and Nutrition. The standard overview of the class, benefits and hazards in one place. PubMed search
  7. Benvenga S and colleagues (2008) — altered intestinal absorption of levothyroxine caused by coffee, Thyroid. The model case for separating a fussy drug from a polyphenol drink by hours. PubMed search

5. Bach Flower Remedies, Homeopathy and Placebo

  1. Thaler K, Kaminski A, Chapman A, Langley T, Gartlehner G (2009) — Bach flower remedies for psychological problems and pain: a systematic review, BMC Complementary and Alternative Medicine. PubMed search
  2. Ernst E (2010) — Bach flower remedies: a systematic review of randomised clinical trials, Swiss Medical Weekly, following an earlier review of flower remedies in Wiener Klinische Wochenschrift (2002). PubMed search
  3. Walach H, Rilling C, Engelke U (2001) — Bach flower remedies in test anxiety: a double-blind, placebo-controlled, randomised trial with partial crossover, Journal of Anxiety Disorders; and Pintov S and colleagues (2005) on Bach flower remedies in childhood ADHD, European Journal of Paediatric Neurology. PubMed search
  4. Shang A and colleagues (2005) — comparative study of placebo-controlled trials of homoeopathy and conventional medicine, The Lancet; and Mathie RT and colleagues (2014) on individualised homeopathic treatment, Systematic Reviews, included because readers deserve the strongest version of the opposing case. Adjacent literature: Bach's system is homeopathy's cousin, not a subset. PubMed search
  5. Hróbjartsson A, Gøtzsche PC (2001) — is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment, New England Journal of Medicine; and Kaptchuk TJ and colleagues (2010) — placebos without deception, a randomised controlled trial in irritable bowel syndrome, PLoS ONE. Why "it helped me" and "it is inert" can both be true. PubMed search

Back to Table of Contents


External Resources

Back to Table of Contents


Connections

Back to Table of Contents